H. R. Hygiene Products Share Price & Earnings Call Analysis

₹62.00+3.30% today
Market cap
₹141 Cr
P/E
12.33
ROE
30.91%
PEG
0.05
Price to sales
1.08
Debt to equity
0.51
EBITDA margin
13.58%
Net profit margin
8.75%
Promoter holding
48.54%
Sales (last year)
₹130 Cr

Potential multibaggers · Q2 FY27

Potential multibaggers in Personal Products
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. 3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Personal Products companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹1,858 Cr55.5
240%+Flat₹408 Cr36.4
3Honasa Consumer Ltd20–40%Up 0–2%₹14,422 Cr57.1
410–20%Flat₹83,720 Cr39.4
510–20%Flat₹64,856 Cr32.7
610–20%Flat₹15,704 Cr20.7

Sign up free to see every company in the sector ranking and track H. R. Hygiene.

Pro shows every company guiding 40%+ revenue growth →Full Personal Products ranking

Financials of H. R. Hygiene

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

H. R. Hygiene

Shareholding breakup across reporting periods.

Aug 2026
Promoters +48.54%
FIIs +8.25%
DIIs +3.55%
Public +39.64%
No. of Shareholders921

Financials of H. R. Hygiene

Quarterly Results

Quarter-by-quarter operating performance

Sales +
Expenses +
Operating Profit
OPM %
Other Income +
Interest
Depreciation
Profit before tax
Tax %
Net Profit +
EPS in Rs

Financials of H. R. Hygiene

Profit & Loss

Annual income statement trend

Mar 2023Mar 2024Mar 2025Mar 2026
Sales +4282115130
Expenses +4075100113
Operating Profit261518
OPM %5.0%8%13%14%
Other Income +0211
Interest1222
Depreciation1111
Profit before tax071216
Tax %-4%26%25%28%
Net Profit +05911
EPS in Rs1.5427.7712.756.41
Dividend Payout %0%0%0%0%

Financials of H. R. Hygiene

Balance Sheet

Capital structure and asset base

Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital22718
Reserves-052425
Borrowings +20252122
Other Liabilities +131838107
Total Liabilities344991171
Fixed Assets +3876
CWIP0000
Investments0000
Other Assets +314183165
Total Assets344991171

Financials of H. R. Hygiene

Cash Flows

Operating, investing and financing cash movement

Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-12-102
Cash from Investing Activity +-0-6-0-0
Cash from Financing Activity +2411-1
Net Cash Flow0-010
Free Cash Flow-2-4-101
CFO/OP-63%48%-58%9%

Financials of H. R. Hygiene

Ratios

Working capital efficiency and return ratios

Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days4028157293
Inventory Days181185108171
Days Payable13283138354
Cash Conversion Cycle88130127110
Working Capital Days7149106130
ROCE %31%34%30%

Others in Personal Products this season

  • JHS Svendgaard Laboratories (Q2 FY27)

    2,077.1 lakhs in the same quarter of 2025, which reflects an approximate year-on-year growth of 10.8%. Key results statement takeaways from JHS Svendgaard Labor

  • Aakaar Medical (Q2 FY27)

    Revenue from operations in H1 FY27: INR 43.72 Cr, up 72.6% YoY from INR 25.32 Cr in H1 FY26 (Page 12, 11, 4) . Key investor presentation takeaways from Aakaar M

  • Recode Studios (Q4 FY26)

    The company plans to sustain marketing spends at about 20% of revenue to support growth and brand visibility, implying continued focus on operating profits…

  • Godrej Consumer (Q2 FY27)

    Consolidated net sales for Q2 FY2027: ₹4,396 crore, up 19% year-on-year; constant currency growth 15% (Page 8) . Key investor presentation takeaways from Godrej